A genetic variant of TMPRSS2 may confer protection against severe COVID-19

By | March 9, 2021
Among a large sample of COVID-19 patients, researchers found that a genetic variant – caused by an amino acid substitution from valine to methionine – is associated with a reduced chance of severe disease.